Retatrutide is a powerful triple agonist peptide that targets GLP-1, GIP (glucose-dependent insulinotropic polypeptide), and glucagon receptors—making it the most comprehensive metabolic peptide in its class. It builds on the progress of earlier compounds like Semaglutide and Tirzepatide by activating three key hormonal pathways involved in appetite regulation, glucose control, and fat metabolism.
This enhanced activity leads to faster, more dramatic fat loss while offering additional therapeutic effects across multiple body systems.
Mechanism of Action
GLP-1 Receptor Agonism: Slows gastric emptying, reduces appetite, regulates insulin secretion
GIP Receptor Agonism: Enhances insulin release, improves glucose tolerance, improves fat metabolism
Glucagon Receptor Agonism: Stimulates energy expenditure and promotes fat breakdown (lipolysis)
Inclusions
Peptide
Diluent
8pcs Insulin Syringes
1pc Reconstituting Syringe
16pcs Alcohol Pads
1pc Vial Cap
1pc Vial Case
1pc Syringe & Alcohol Pads Case
